bpc-157 fatigue Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review Potential Side Effects of BPC-157

While animal studies have shown promising results for tissue repair and anti-inflammatory effects, large-scale randomized controlled trials in humans are lacking

Weight Loss14mg/wk Starts at 0.3 or 0.5 mg, then builds to 1 mg

10.2174/13816128113199990421 100 SeiwerthS.RucmanR.TurkovicB.SeverM.KlicekR.RadicB.et al (2018)

The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary